作者
Turid Aas, Anne-Lise Børresen, Stephanie Geisler, Birgitte Smith-Sørensen, Hilde Johnsen, Jan E Varhaug, Lars A Akslen, Per E Lønning
发表日期
1996/7/1
期刊
Nature medicine
卷号
2
期号
7
页码范围
811-814
出版商
Nature Publishing Group US
简介
The mechanisms causing resistance to chemotherapeutic drugs in cancer patients are poorly understood. Recent evidence suggests that different forms of chemotherapy may exert their cytotoxic effects by inducing apoptosis1. The tumor suppressor gene P53 has a pivotal role inducing apoptosis in response to cellular damage. In vitro investigations have shown intact p53 to play a critical role executing cell death in response to treatment with cytotoxic drugs like 5–fluorouracil, etoposide and doxorubicin2. Recently, mutations in the P53 gene were found to confer resistance to anthracyclines in a mouse sarcoma tumor model3, and overexpression of the p53 protein (which, in most cases, is due to a mutated gene) was found to be associated with lack of response to cisplatin–based chemotherapy in non–small cell lung cancer4. Previous studies have shown mutations in the P53 gene or overexpression of the p53 …
引用总数
1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202452753487143544644413735443031293629392618302132172215168
学术搜索中的文章